The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study

BACKGROUND/AIMS: The optimal treatment (Tx) for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) patients with brain metastasis (BM) remains to be determined. METHODS: A retrospective review was conducted on 77 NSCLC patients with synchronous BM who underwent first-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jin-Hyuk, Choi, Yong Won, Lee, Hyun Woo, Kang, Seok Yun, Jeong, Geum Sook, Ahn, Mi Sun, Oh, Young-Taek, Noh, O kyu, Kim, Se-Hyuk, Roh, Tae Hoon, Sheen, Seung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925938/
https://www.ncbi.nlm.nih.gov/pubmed/35167736
http://dx.doi.org/10.3904/kjim.2021.315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925938/
https://www.ncbi.nlm.nih.gov/pubmed/35167736
http://dx.doi.org/10.3904/kjim.2021.315

Ejemplares similares